Previous Article | Next Article ![]()
J. Virol., Jul 1997, 5140-5147, Vol 71, No. 7
MT Dittmar, G Simmons, Y Donaldson, P Simmonds, PR Clapham, TF Schulz and RA Weiss
In order to characterize the biological properties of human
immunodeficiency virus type 1 (HIV-1) variants from different tissues
(peripheral blood mononuclear cells [PBMC], lymph node, spleen, brain, and
lung) of one patient, we have chosen long-range PCR to amplify virtually
full-length HIV proviruses and to construct replication- competent viruses
by adding a patient-specific 5' long terminal repeat. To avoid selection
during propagation in CD4+ target cells, we transfected 293 cells and used
the supernatants from these cells as challenge viruses for tropism studies
after titration on human PBMC. Despite differences in the V3 loop of the
major variants found in brain and lung compared to lymphoid tissues all
recombinant HIV clones obtained showed identical cell tropism and
replicative kinetics. After infection of human PBMC these viruses
replicated with similar kinetics, with a slow/low-titer,
non-syncytium-inducing phenotype. In contrast to the prediction of
macrophage tropism, drawn from the V3 loop sequence, none of these viruses
infected monocyte-derived macrophages. The challenge of blood dendritic
cells by these recombinant viruses in the presence of tumor necrosis factor
alpha, granulocyte-macrophage colony- stimulating factor, and interleukin-4
resulted in a productive infection only after adding stimulated CD4+ T
lymphocytes. Therefore, the biological properties of the HIV-1 variants
derived from nonlymphoid tissue of this patient did not differ from those
of HIV-1 variants from lymphoid tissue with respect to tropism for primary
cells such as PBMC, macrophages, and blood dendritic cells.
Copyright © 1997, American Society for Microbiology
Biological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR
Virology Laboratory, Chester Beatty Laboratories, Institute of Cancer Research, London, United Kingdom. matthias@icr.ac.uk
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|